Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
Paying user area
Try for free
Pfizer Inc. pages available for free this week:
- Balance Sheet: Assets
- Analysis of Short-term (Operating) Activity Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Analysis of Geographic Areas
- Enterprise Value to EBITDA (EV/EBITDA)
- Price to FCFE (P/FCFE)
- Debt to Equity since 2005
- Total Asset Turnover since 2005
- Price to Earnings (P/E) since 2005
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Pfizer Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Pfizer Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)
Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-28), 10-Q (reporting date: 2025-06-29), 10-Q (reporting date: 2025-03-30), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-29), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-10-01), 10-Q (reporting date: 2023-07-02), 10-Q (reporting date: 2023-04-02), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-10-02), 10-Q (reporting date: 2022-07-03), 10-Q (reporting date: 2022-04-03), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-10-03), 10-Q (reporting date: 2021-07-04), 10-Q (reporting date: 2021-04-04).
The composition of liabilities and stockholders’ equity exhibited several notable shifts over the observed period, spanning from April 2021 to December 2025. Overall, the balance between liabilities and equity fluctuated, with a general trend towards increased equity percentages in the later periods. Current liabilities initially represented a significant portion of the total, but their relative weight decreased over time, while noncurrent liabilities demonstrated more stability.
- Current Liabilities
- Current liabilities, as a percentage of total liabilities and equity, peaked at 24.28% in July 2022 before generally declining to 17.77% by December 2025. This decrease suggests improved short-term liquidity management or a shift in financing strategies. Within current liabilities, trade accounts payable remained relatively stable, fluctuating between approximately 2.48% and 3.45%. Accrued compensation and related items showed more variability, peaking at 1.84% in December 2021 and decreasing to 1.73% in December 2025. Deferred revenues experienced a significant decrease from 3.17% in October 2022 to 0.38% in December 2025. Other current liabilities demonstrated a consistent decline from 13.74% in December 2021 to 8.96% in December 2025.
- Noncurrent Liabilities
- Noncurrent liabilities remained a substantial component of the capital structure, consistently representing between 29.76% and 40.31% of the total. Long-term debt, excluding the current portion, was the largest contributor, generally ranging between 16.68% and 28.39%. Pension and postretirement benefit obligations showed a gradual decline, decreasing from 3.25% in April 2021 to 0.98% in December 2025. Other taxes payable decreased from 7.40% in April 2021 to 1.73% in December 2025. Other noncurrent liabilities exhibited a slight increase over the period, moving from 4.21% to 7.07%.
- Stockholders’ Equity
- Total stockholders’ equity increased as a percentage of total liabilities and equity from 41.22% in April 2022 to 41.69% in December 2025. A significant feature of the equity section is the substantial negative balance of treasury stock, which consistently reduced the overall equity position. Retained earnings constituted the largest portion of equity, fluctuating between approximately 40.90% and 60.48%. Additional paid-in capital remained relatively stable, generally between 40.90% and 56.04%. Accumulated other comprehensive loss remained consistently negative, though its impact lessened over time.
- Short-term Borrowings
- Short-term borrowings demonstrated considerable volatility, decreasing from 2.74% in April 2021 to 1.23% in December 2021, then increasing to 5.52% in June 2024 before decreasing again to 1.52% in December 2025. This suggests active management of short-term financing needs.
- Total Liabilities and Equity
- The proportion of total liabilities decreased from 58.62% in July 2021 to 51.36% in December 2022, then increased to 58.31% in December 2023, and finally decreased to 58.31% in December 2025. This indicates a dynamic shift in the company’s capital structure, with a tendency towards a greater reliance on equity financing in the later periods.
In summary, the observed trends suggest a company actively managing its liabilities, particularly short-term borrowings and deferred revenues. The increasing proportion of equity in the capital structure, coupled with the decreasing proportion of current liabilities, may indicate strengthening financial health and a strategic shift towards long-term financial stability.